BRADYKININ is an endogenous polypeptide with great biologic activity.' It was first described by Rocha e Silva et al.,2 and thus named for the slow contraction it causes on the isolated intestine. Using a combination of chromatography and electrophoresis, Elliott et al.,3 in 1960, isolated the pure substance. The synthesis of bradykinin by Boissonnas et al. 4 made possible its widespread use in a variety of investigations. The identity between natural and synthetic bradykinin seems to be established.5 Effects of this drug have been described on capillary permeability,6 on smooth muscle,6 on systemic and pulmonary blood vessels and circulation,6-1" and locally, on tissues, causing pain,6 edema,'2 and migration of leukocytes. '3 Both in animals and in man, bradykinin has a powerful vasodilatory action.6 7 9-11, 14 The general hemodynamic effects induced by a continuous intravenous administration of bradykinin have not been studied by cardiac catheterization except in the dog." This investigation was undertaken to study the circulatory alterations occurring during a constant-rate intravenous infusion of bradykinin in man submitted to simultaneous right-and left-heart catheterization.
Material and Methods
The studies were performed in ten male patients, aged 21 to 47 years ( sures was referred to a horizontal plane at the mid-axillary line of the patient lying in supine position. Mean pressures were obtained by electronic integration and were measured during at least three respiratory cycles. In order to determine the cardiac output by the Fick principle, the expired air was collected during five minutes in a Neoprene bag and immediately analyzed by the micro-Scholander technic 16 for the determination of the oxygen consumption. At a midpoint of the expired air collection, blood samples were taken simultaneously from the brachial and pulmonary ar-teries, and oxygen contents were determined.17
The solution of bradykinin * (2.5 mg. per 100 ml. of physiologic saline) was administered through the polyethylene catheter placed in the superior or inferior vena cava, with use of a motor-driven syringe (infusion-withdrawal pump, Harvard Apparatus Company), at a constant rate of infusion.
Durinig the conitrol period, the following data were obtained, usually in duplicate: pressures in the brachial artery, the pulmonary artery, and the left atrium; and the cardiac output by the Fick method. After these procedures had been completed, the intravenous injection of bradykinin was started. The rate of infusion was gradually increased until a dose was reached sufficient to provoke fall of the brachial arterial pressure or an increase in ventricular rate, which was continuously monitored on the oscilloscope. Usually a dose large enough to elicit unpleasant side effects was avoided. In fact, only three patients complained of slight sensation of warmth in the face and limbs. In one of these patients a visible reddening of the face and neck was noted. All three patients received doses exceeding The systemic arterial pressure decreased significantly during the intravenous infusion of the drug. This decrease in pressure was accompanied by a simultaneous and equally significant increase of the cardiac output, with no consistent change in total oxygen consumption. Therefore, the present investigation has confirmed that bradykinin has a vasodilatory effect on the systemic circulation, since the calculated total peripheral resistance fell appreciably in all patients.
The fall in resistance could explain not only the decrease in pressure but it could also be responsible for a compensatory increase of the cardiac output. As is already known, a lowered pressure acting upon the arterial stretch receptors elicits a reflex acceleration of the heart rate. In addition, a drop in pressure would offer less resistance to ventricular ejection and could allow an increase of the stroke volume. Furthermore, as was experimentally demonstrated by Sarnoff et al.,20 a decrease of pressure in the carotid sinus reflexly augments the ventricular contractility at any given filling pressure, thus permitting a more complete systolic empty- ing. These effects would be enhanced by the catecholamines discharged from the adrenal medulla in response to a lowering of the pressure in the carotid sinus region.7 20 Since the increased cardiac output noted in these experiments was coincident with a significant elevation of both the heart rate and the stroke volume, the above-mentioned compensatory mechanisms could have been operative during bradykinin administration. Further support for this interpretation could be found in the secondary rise of the systemic blood pressure following an initial fall determined by a single intravenous injection of bradykinin.7 Moreover, bradykinin might have a direct releasing action upon the catecholamines stored in the vascular walls or the suprarenal medulla, and its hypotensive effects can be potentiated by sympatholytic agents phenoxybenzamine (Dibenzyline) and by catecholamine-depleting drugs (reserpine) .7 During bradykinin infusion, the left ventricular work either increased or decreased (table 1) , depending on whether the rise of the cardiac output was proportionally greater or lesser than the fall of the systemic arterial pressure. Coincident with the rise or fall of the left ventricular work, the tensiontime index increased or decreased. Since the tension-time index correlates well with the myocardial oxygen consumption,19 the results obtained suggest that there was no appreciable modification of the mechanical efficiency of the left ventricle during bradykinin administration.
In the pulmonary circulation, no significant change in pressures was noted either in the arterial or the venous side (left atrium). The respiratory variations of the intravascular and thetic bradykinin were studied in ten patients submitted to simultaneous right-and leftheart catheterization. A significant drop in systemic arterial pressure and in total peripheral resistance was observed, coincident with an increase of the cardiac output, heart rate, and stroke volume. There was no consistent change of the pulmonary arterial and left atrial pressures, but the pulmonary vascular resistance decreased significantly.
